Life sciences companies are faced with an intricate web of legal updates. The Board of Directors needs to know what those updates are, and how those updates impact the company — now and in the future.
Please join Buchanan Life Sciences and the ACC of New Jersey as we consider best practices for keeping the Board informed and discuss the latest “cutting edge” topics impacting our industry. Both Buchanan lawyers and in-house practitioners will share their perspectives about key FDA, antitrust, litigation, employment and intellectual property law updates.
Life Sciences Company professionals who work in all aspects of the business (e.g. executive leadership, legal, finance, product pricing, product life cycle management, chief strategy officer, risk management, business development/licensing, market access, human resources, regulatory, medical, compliance) are invited to attend.